VEGFA and pancreatic neuroendocrine tumor: Keklikoglou et al., by genetic deletion of periostin (a matricellular protein expressed by stromal cells) in RIP1-Tag2 mice blunted tumor, demonstrated that revascularization and progression of pancreatic neuroendocrine tumors under extended VEGFA blockade are dependent on it [106].